Added 9 months ago Drug news
Urovant Sciences licenses vibegron from Merck Inc. and will initiate a Phase III trial in 2017 for overactive bladder treatment.
Roivant Sciences, announced the formation of Urovant Sciences, a new company focused on developing innovative therapies for urologic conditions. Urovant's...
Added 2 years ago Drug news
Phase III extension studies show advantages of Botox (onabotulinumtoxinA) in urinary incontinence- Allergan
Allergan has announced that results from an extension study of two phase III trials showed that long-term Botox (onabotulinumtoxinA) treatment...
Added 3 years ago Drug news
In an early benefit assessment, the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether Myrbetriq/Betmiga (mirabegron),...
An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.
See information on best practice in solid organ transplantation, and expert discussions on related hot topics.
Explore the pathophysiology and treatment options for Fabry disease, a deficiency of the lysosomal enzyme alpha-galactosidase A
Discover and overview of hypophosphatasia and details required to facilitate the timely and accurate detection of low alkaline phosphatase.
Recommendations apply to men aged 40 years or older who seek professional help for various non-neurogenic benign forms of LUTS...
Added 2 years ago
Purpose: To investigate the association between overactive bladder (OAB) and coronary artery disease (CAD) as demonstrated on coronary angiography in patients > 65 years.
Added 2 months ago
Comparative assessment of the efficacy of onabotulinumtoxinA and oral therapies (anticholinergics and mirabegron) for overactive bladder: a systematic review and network meta-analysis.
Objectives: To compare the efficacy of onabotulinumtoxinA, mirabegron, and anticholinergics in adults with idiopathic overactive bladder (OAB) using network meta-analysis (NMA).
Added 2 months ago
Evaluate clinical aspects associated with the presence of nocturnal enuresis (NE) in children with a diagnosis of overactive bladder (OAB).
Added 1 year ago
- Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
- Credits available
- Registration required
- Subscription fee